Toxic neuropathy vs. diabetic neuropathy

Authors

  • Patricia Simkova Institute of Applied Biology, Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovak Republic
  • Marcela Capcarova Institute of Applied Biology, Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovak Republic

DOI:

https://doi.org/10.36547/ae.2024.6.2.57-60

Keywords:

toxic neuropathy, diabetic neuropathy, therapeutic agents

Abstract

Peripheral neuropathy is a significant clinical issue that affects around 15% of people over 40. Peripheral neuropathies can have a wide range of etiologies, such as dietary deficits, viral and metabolic illnesses, and inherited disorders. Another major cause of acquired polyneuropathy is toxic neuropathies caused by xenobiotics that target peripheral nervous system components. Diabetes is by far the most prevalent cause of neuropathy. Actually, up to 50% of diabetic patients may acquire neuropathy at some point throughout their illness, with neuropathy being present in about 30% of cases. There are several ways that diabetes can harm the peripheral nerve system, but distal symmetric polyneuropathy is the most typical symptom. Among additional forms of harm include radiculoplexopathy, autonomic neuropathy, and small fiber predominate neuropathy. In this review we will summary a general characteristics of both toxic and diabetic neuropathy.

Downloads

Published

2024-10-03

How to Cite

Simkova, P., & Capcarova, M. (2024). Toxic neuropathy vs. diabetic neuropathy. Archives of Ecotoxicology, 6(2), 57–60. https://doi.org/10.36547/ae.2024.6.2.57-60

Issue

Section

Mini Review

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.